US Edition
News from discernmoney.com
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top discernmoney.com News
War · New YorkU.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind weight-loss treatments Ozempic and Wegovy.Metsera, based in New York, has no products on the market, but it is developing oral and injectable treatments. That includes some potential treatments that could target lucrative fields for obesity and diabetes. The deal come…See the Story
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
49% Center coverage: 45 sources
United States · United StatesIt was a big fight over small fees that added up to astronomical sums, but it may be nearly over. After some 20 years of legal battling, merchants and credit card-processing giants Visa and Mastercard finally agreed to a settlement on Monday over swipe fees. But not everyone’s swiping right on the terms of the new deal. Honorable No Charge Not all credit cards are created equal, which drives US merchants crazy. While Americans have grown to lo…See the Story
Visa, Mastercard Swipe Right on Fee Settlement. Will a Court Sign Off?
67% Center coverage: 3 sources
